| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Laboratory of Medicinal Chemistry and Radiopharmacy [B. F. J., B. G.], Laboratory of Biomedical Magnetic Resonance [B. F. J., R. J. D., B. G.], Radiobiology and Radioprotection Unit [V. G.], Laboratory of Pharmacotherapy [P. S., O. F.], and Laboratory of Pharmacokinetics, Metabolism, Nutrition and Toxicology [V. P. V., N. D.], Université Catholique de Louvain, B-1200 Brussels, Belgium, and EPR Research Center for the Study of Viable Biological Systems, Dartmouth Medical School, Hanover, New Hampshire 03755 [J. O.]
The effects of insulin on tumor oxygenation, perfusion, oxygen consumption,and radiation sensitivity were studied on two different mouse tumor models (TLT, a liver tumor, and FSAII, a fibrosarcoma). Anesthetized mice were infused with insulin i.v. at a rate of 16 milliUnits/kg/min for 25 min. Local tumor oxygenation measurements were carried out using two independent techniques: electron paramagnetic resonance oximetry and a fiber-optic device (OxyLite). Two complementary techniques were also used to assess the blood flow inside the tumor: a laser Doppler system (OxyFlo) and contrast-enhanced magnetic resonance imaging. The oxygen consumption rate of tumor cells after in vivo insulin infusion was measured using high frequency electron paramagnetic resonance oximetry. To know if insulin was able to enhance radiation-induced tumor regrowth delay, tumor-bearing mice were treated with 16 Gy of 250 kV radiation dose after insulin infusion.
We provide evidence that insulin increases the local pressure of oxygen of tumors (from 03 mm Hg to 811 mm Hg) as well as the tumor response to irradiation (increasing regrowth delay by a factor of 2.11). We found that the insulin-induced increase of tumor pressure of oxygen: (a) is not caused by an increase in the tumor blood flow, which is even decreased after insulin infusion; (b) is because of a decrease in the tumor cell oxygen consumption (in vivo insulin consumed oxygen three times slower than control cells); and (c) is inhibited by a nitric oxide (NO) synthase inhibitor, N
-nitro-L-arginine methyl ester, when injected i.p. at 15 µmol/kg-1, 1 h before insulin infusion. We demonstrate by immunoblotting that the NO pathway involves a phosphorylation of endothelial NO synthase and showed a concomitant increase in the cyclic GMP tumor level.
These findings provide unique insights into biological processes in tumors, new possible management for treating cancer patients, and raise major questions about the role of insulin secretion (fasting status and diabetes) in the clinical response of tumors to radiation therapy.
This article has been cited by other articles:
![]() |
A. S. Caudle, H. J. Kim, J. E. Tepper, B. H. O'Neil, L. A. Lange, R. M. Goldberg, S. A. Bernard, B. F. Calvo, and M. O. Meyers Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer Ann. Surg. Oncol., July 1, 2008; 15(7): 1931 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Crokart, B. F. Jordan, C. Baudelet, G. O. Cron, J. Hotton, K. Radermacher, V. Gregoire, N. Beghein, P. Martinive, C. Bouzin, et al. Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption Clin. Cancer Res., January 15, 2007; 13(2): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ansiaux, C. Baudelet, B. F. Jordan, N. Crokart, P. Martinive, J. DeWever, V. Gregoire, O. Feron, and B. Gallez Mechanism of Reoxygenation after Antiangiogenic Therapy Using SU5416 and Its Importance for Guiding Combined Antitumor Therapy Cancer Res., October 1, 2006; 66(19): 9698 - 9704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ansiaux, C. Baudelet, G. O. Cron, J. Segers, C. Dessy, P. Martinive, J. De Wever, J. Verrax, V. Wauthier, N. Beghein, et al. Botulinum Toxin Potentiates Cancer Radiotherapy and Chemotherapy Clin. Cancer Res., February 15, 2006; 12(4): 1276 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Crokart, K. Radermacher, B. F. Jordan, C. Baudelet, G. O. Cron, V. Gregoire, N. Beghein, C. Bouzin, O. Feron, and B. Gallez Tumor Radiosensitization by Antiinflammatory Drugs: Evidence for a New Mechanism Involving the Oxygen Effect Cancer Res., September 1, 2005; 65(17): 7911 - 7916. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Yu, B.-R. Lin, H.-S. Lee, C.-T. Shun, C.-C. Yang, T.-Y. Lai, C.-T. Chien, and S.-M. Hsu Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1005 - F1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ilangovan, S. Osinbowale, A. Bratasz, M. Bonar, A. J. Cardounel, J. L. Zweier, and P. Kuppusamy Heat shock regulates the respiration of cardiac H9c2 cells through upregulation of nitric oxide synthase Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1472 - C1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sonveaux, C. Dessy, P. Martinive, X. Havaux, B. F. Jordan, B. Gallez, V. Gregoire, J.-L. Balligand, and O. Feron Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor Arterioles: Implications for Cancer Treatment Cancer Res., May 1, 2004; 64(9): 3209 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sonveaux, A. Brouet, X. Havaux, V. Gregoire, C. Dessy, J.-L. Balligand, and O. Feron Irradiation-induced Angiogenesis through the Up-Regulation of the Nitric Oxide Pathway: Implications for Tumor Radiotherapy Cancer Res., March 1, 2003; 63(5): 1012 - 1019. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |